Business Finance Media Technology Policy Wealth Insights Interviews

Art Art Fairs Art Market Art Reviews Auctions Galleries Museums Interviews

Lifestyle Nightlife & Dining Style Travel Interviews

Power Index Nightlife & Dining Art A.I. PR

About About Observer Advertise With Us Reprints

Anne Wojcicki on 23andMe’s Second Life

Anne Wojcicki says 23andMe’s 13 million users enable research "like a Google query," powering studies from GLP-1 drugs to rare traits.

There’s a lot of confusion around 23andMe: Is the company still in business? Is it now owned by Regeneron, the biotech company that once tried to buy it? Are its genetic test kits still available for sale? And if you’re a customer, what happens to your data? It’s been about a year since 23andMe plummeted into Chapter 11 following a series of financial and regulatory misfortunes. Last summer, in bankruptcy court, the company’s founder and former CEO, Anne Wojcicki, won a bidding war against Regeneron and took over 23andMe’s assets, most importantly the genetic data of millions of users, for $305 million. The company now sits under TTAM Research Institute, a nonprofit Wojcicki established to take 23andMe private.

Sign Up For Our Daily Newsletter

Thank you for signing up!

By clicking submit, you agree to our terms of service and acknowledge we may use your information to send you emails, product samples, and promotions on this website and other properties. You can opt out anytime.

Its nonprofit status means 23andMe is now more focused on making a positive impact than selling test kits. “We have, in many........

© Observer